Cardiovascular Effects of Chronic Sildenafil (Viagra) Treatment in Diabetic Subjects With Endothelial Dysfunction

Trial Profile

Cardiovascular Effects of Chronic Sildenafil (Viagra) Treatment in Diabetic Subjects With Endothelial Dysfunction

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Mar 2016

At a glance

  • Drugs Sildenafil (Primary)
  • Indications Diabetic cardiomyopathy
  • Focus Pharmacodynamics
  • Acronyms CECSID
  • Most Recent Events

    • 10 Mar 2016 Results published in the Journal of Clinical Endocrinology and Metabolism
    • 14 May 2012 Actual patient number is 59 according to ClinicalTrials.gov.
    • 14 May 2012 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top